Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes

被引：0
|
作者：
Hermansen, Kjeld
Heller, Simon
Andersen, Marc
Russell-Jones, David L.
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A529 / A530
页数：2
相关论文
共 50 条
  • [21] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Aagren, M.
    Liu, F.
    Bouchard, J.
    Conner, C.
    VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
  • [22] Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis
    Tunis, Sandra L.
    Minshall, Michael E.
    Conner, Christopher
    McCormick, John I.
    Kapor, Jovana
    Yale, Jean-Francois
    Groleau, Danielle
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1273 - 1284
  • [23] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
    Terrés, CR
    Rodríguez, J
    Bolinder, B
    de Pablos, P
    DIABETOLOGIA, 2004, 47 : A345 - A345
  • [24] The Effects of Subcutaneous Insulin NPH and Detemir on Glucose Flux and Lipolysis Following a Period of Insulin Withdrawal in Patients With Type 1 Diabetes
    Herring, Roselle
    Shojaee-Moradie, Fariba
    Jackson, Nicola
    Jones, Richard
    Umpleby, Margot
    Russell-Jones, David L.
    DIABETES, 2013, 62 : A492 - A492
  • [25] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [26] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - Response to Home et al.
    Kiess, W
    Raile, K
    Galler, A
    Kapellen, T
    DIABETES CARE, 2004, 27 (10) : 2567 - 2568
  • [27] Insulin Detemir Increases Cerebral Glucose Metabolism Compared to NPH Insulin in Human Type 1 Diabetes: Possible Explanation for Differences in Weight Gain?
    Van Golen, Larissa W.
    Huisman, Marc C.
    Ijzerman, Richard G.
    Hoetjes, Nikie J.
    Schwarte, Lothar A.
    Schober, Patrick
    Hoogma, Roel P.
    Drent, Madeleine L.
    Lammertsma, Adriaan A.
    Diamant, Michaela
    DIABETES, 2011, 60 : A421 - A421
  • [28] Subcutaneous insulin detemir compared with NPH insulin increases brain potential responses with similar systemic metabolic effects in people with Type 1 diabetes
    Herring, R.
    Shojaee-Moradie, F.
    Umpleby, M.
    Jackson, N.
    Jones, R.
    Derk-Jan, D.
    Knight, R.
    Russell-Jones, D.
    DIABETIC MEDICINE, 2014, 31 : 62 - 62
  • [29] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE-2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
    Buysman, E.
    Conner, C.
    Liu, F.
    Aagren, M.
    Bouchard, J.
    VALUE IN HEALTH, 2011, 14 (03) : A98 - A98
  • [30] A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial
    Buysman, Erin K.
    Conner, Christopher
    Liu, Fang
    Aagren, Mark
    Bouchard, Jonathan
    DIABETES, 2011, 60 : A628 - A628
12345